Extracellular high mobility group box chromosomal protein 1 promotes drug resistance by increasing the expression of P-glycoprotein expression in gastric adenocarcinoma cells

Molecular Medicine Reports

Volumn 9, Issue 4, 2014, Pages 1439-1443

  Yin, Yuping ^a   Li, Wei ^a   Deng, Meizhou ^a   Zhang, Peng ^a   Shen, Qian ^b   Wang, Guobing ^a   Tao, Kaixiong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gastric cancer; High mobility group box chromosomal protein 1; Multidrug resistance; P glycoprotein

Indexed keywords

DOXORUBICIN; HIGH MOBILITY GROUP B1 PROTEIN; MULTIDRUG RESISTANCE PROTEIN; VINCRISTINE;

APOPTOSIS ASSAY; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER RESISTANCE; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MTT ASSAY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STOMACH ADENOCARCINOMA; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; HUMANS; P-GLYCOPROTEIN; STOMACH NEOPLASMS;

EID: 84896517100     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1961     Document Type: Article

References (23)

1. Goodwin GH, Sanders C and Johns EW: A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 38: 14-19, 1973.
2. Bustin M, Lehn DA and Landsman D: Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1049: 231-243, 1990. (Pubitemid 20224615)
3. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A and Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999. (Pubitemid 29329996)
4. Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342, 2005. (Pubitemid 40516158)
5. Song B, Song WG, Li ZJ, Xu ZF, Wang XW, Wang CX and Liu J: Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. Cell Biochem Funct 30: 11-17, 2011.
6. Kuniyasu H, Yano S, Sasaki T, Sasahira T, Sone S and Ohmori H: Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol 166: 751-760, 2005.
7. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
8. Gillet JP and Gottesman MM: Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1. Drug Resist Updat 15: 2-4, 2012.
9. Borst P and Elferink RO: Mammalian ABC transporters in health and disease. Annu Rev Biochem 71: 537-592, 2002. (Pubitemid 34800230)
10. Nowak P, Nystrom J and Troseid M: High levels of HMGB1 in plasma may be due to ex vivo cell necrosis. Anticancer Res 32: 4067-4069, 2012.
11. Akaike H, Kono K, Sugai H, Takahashi A, Mimura K, Kawaguchi Y and Fujii H: Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer. Anticancer Res 27: 449-457, 2007.
12. Lu B, Wang H, Andersson U and Tracey KJ: Regulation of HMGB1 release by inflammasomes. Protein Cell 4: 163-167, 2013.
13. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ and Lotze MT: HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29: 5299-5310, 2010.
14. Satta T, Isobe K, Yamauchi M, Nakashima I and Takagi H: Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer. Cancer 69: 941-946, 1992.
15. Wallner J, Depisch D, Gsur A, Götzl M, Haider K and Pirker R: MDR1 gene expression and its clinical relevance in primary gastric carcinomas. Cancer 71: 667-671, 1993. (Pubitemid 23051364)
16. Misleh JG, Santoro P, Strasser JF and Bennett JJ: Multidisciplinary management of gastric cancer. Surg Oncol Clin N Am 22: 247-264, 2013.
17. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM and Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389, 1986. (Pubitemid 17210152)
18. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE and Gottesman MM: P-glycoprotein: from genomics to mechanism. Oncogene 22: 7468-7485, 2003. (Pubitemid 37487170)
19. Choi YR, Kim H, Kang HJ, Kim NG, Kim JJ, Park KS, Paik YK, Kim HO and Kim H: Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Res 63: 2188-2193, 2003. (Pubitemid 36538625)
20. Zeh HJ III and Lotze MT: Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother 28: 1-9, 2005.
21. Kono K, Mimura K and Kiessling R: Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation. Cell Death Dis 4: e688, 2013.
22. Revesz L: Effect of tumour cells killed by x-rays upon the growth of admixed viable cells. Nature 178: 1391-1392, 1956.
23. Chung HW, Lee SG, Kim H, Hong DJ, Chung JB, Stroncek D and Lim JB: Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. J Transl Med 7: 38, 2009.